Clinical Trials
- Brain and Other Nervous System Cancers, Pediatric Cancers
A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma
- Date03/18/2018
- Brain and Other Nervous System Cancers, Pediatric Cancers
A Phase 2 Study of Dabrafenib (NSC# 763760) With Trametinib (NSC# 763093) After Local Irradiation in Newly-Diagnosed BRAF V600-Mutant High-Grade Glioma (HGG)
- Date09/10/2020
- Brain and Other Nervous System Cancers
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-Controlled Study of AG-881 in Subjects With Residual or Recurrent Grade 2 Glioma With an IDH1 or IDH2 Mutation
- GenderBoth
- Date08/05/2020
- Brain and Other Nervous System Cancers, Lung Cancer, Melanoma
A Phase II Trial of Pembrolizumab Plus Bevacizumab in Patients With Metastatic Melanoma or Non-small Cell Lung Cancer With Untreated Brain Metastases
- Ages18 years and older
- GenderBoth
- Date05/26/2016
- Brain and Other Nervous System Cancers, Pediatric Cancers, Phase 1 Cancers
A Study Comparing Two Carboplatin Containing Regimens for Children and Young Adults With Previously Untreated Low Grade Glioma
- Ages21 years and younger
- GenderBoth
- Date07/08/2015
- Brain and Other Nervous System Cancers, Pediatric Cancers
A Target Validation/Phase1 Study of BGB-290 in Combination With Temozolomide in Adolescent and Young Adult IDH1/2 Newly Diagnosed and Recurrent Mutant Gliomas
- Date09/24/2020
- Brain and Other Nervous System Cancers
GBM AGILE: Global Adaptive Trial Master Protocol: An International, Seamless Phase II/III Response Adaptive Randomization Platform Trial Designed To Evaluate Multiple Regimens In Newly Diagnosed and Recurrent GBM
- Date07/15/2020
- Brain and Other Nervous System Cancers
Genomically-Guided Treatment Trial in Brain Metastases
- Ages18 years and older
- GenderBoth
- Date02/10/2020
- Brain and Other Nervous System Cancers, Leukemia, Lymphoma, and Myeloma, Sarcoma Cancers
NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Screening Protocol
- Ages1 year - 21 years
- GenderBoth
- Date06/17/2018
- Bladder Cancer, Brain and Other Nervous System Cancers, Breast Cancer, Colorectal Cancer, Gynecological Cancers, Head and Neck Cancers, Kidney Cancer, Leukemia, Lymphoma, and Myeloma, Liver Cancer, Lung Cancer, Melanoma, Other Cancers, Pancreatic Cancer, Prostate Cancer, Sarcoma Cancers, Stomach and Esophagus, Thyroid and Other Endocrine Cancers
NCI-MATCH: Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors or Lymphomas
- Ages18 years and older
- GenderBoth
- Date08/07/2016